MAPT and Anxiety: In conclusion, our study provides evidence for the detrimental effects of blocking adiponectin receptors by i.p. administration with an adiponectin receptor antagonist, highlighting its negative effects in interrupting adiponectin receptors in the hippocampus and its impact on tau hyperphosphorylation, anxiety-like behavior, cognitive function, and hippocampal neurogenesis.